Cor Vasa 2008, 50(6):232-234

Problémy s novými a novějšími hypolipidemiky

Jiří Widimský
Klinika kardiologie, Institut klinické a experimentální medicíny, Subkatedra kardiologie IPVZ, Praha, Česká republika

Published: June 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Widimský J. Problémy s novými a novějšími hypolipidemiky. Cor Vasa. 2008;50(6):232-234.
Download citation

References

  1. Nissen SE, Tardiff J-C, Nicholls SJ, et al, for the ILLUSTRATE Investigators. Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med 2007;356:1304-16. Go to original source... Go to PubMed...
  2. Barter PJ, Carefield M, Eriksson M, et al, for the ILLUMINATE Investigators. Effects of torcetrapib in patiens with high risk for coronary events. N Engl J Med 2007;357:2109-22. Go to original source... Go to PubMed...
  3. Nissen SE, Tuzcu EM, Libby P, et al, for the CAMELOT Investigators. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004;292: 2217-25. Go to original source... Go to PubMed...
  4. Rader DJ. Illuminating HDL - is it still a viable therapeutic target? N Engl J Med 2007; 357:2180-1. Go to original source... Go to PubMed...
  5. Kastelein JJP, Akdim F, Stroes ESG, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008;358:1431-43. Go to original source... Go to PubMed...
  6. Brown BG, Taylor AJ. Does ENHANCE diminish confidence in lowering LDL or in ezetimibe? N Engl J Med 2008;358:1504-7. Go to original source... Go to PubMed...
  7. Smilde TJ, van Wissen S, Wollersheim H, et al. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial. Lancet 2001;357:577-81. Go to original source...
  8. Drazen JM, Jarcho JA, Morrissey S, Curfman GD. Cholesterol lowering and ezetimibe. N Engl J Med 2008; 358:1507-8. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.